SHOCKWAVE THERAPY PRACTICAL COURSE

CLINIC003

A combined e-learning & taught course where you will be fully prepared to bring this effective treatment into your practice. Learn to diagnose and treat a wide range of soft tissue conditions in the foot & ankle and introduce a highly effective and evidenced based treatment "shockwave therapy".  

More details

£ 229.17(£ 229.17 VAT excl.)

More info

This one day course includes much more than the simple mechanics of shockwave. You will learn how shockwave works, when to use it as part of your management and which treatment protocol works best. Each condition covered includes a detailed management plan.

TOPICS

Physiology of Shockwave, Diagnostic Indicators, How to apply shockwave, Practical sessions, Contra-indications, Treatment protocols, Top tips for best outcomes, promoting your practice and much more..

ONE DAY'S HANDS-ON PRACTICAL TRAINING INCLUDED IN YOUR COURSE FEE

DURATION 1 Day

CPD HOURS 6

PRICE £275 inc VAT

INSTRUCTOR

Mr Stuart Metcalfe - Consultant Podiatric Surgeon

25yrs experience

MPhil in Clinical Biomechanics

Author of more than thirty clinical papers

International lecturer

Author of key text on injection therapy

WHAT WILL I LEARN?

What conditions can be treated

  • How shockwave works
  • How to apply shockwave safely
  • Clinical protocols for the conditions you will treat
  • Contra-indications
  • Machine types and which is best for you
  • How to market shockwave in your practice

INCLUDES

  • Complete e-learning course with a 1 day taught course with hands on training covering all the key topics you need 
  • Course notes
  • All lectures 
  • Tea / coffee 
  • CPD Certification
  • Lunch

Click Here for Course Location

SPECIALS  |  NEW PRODUCTS  |   LOCATION  |   CONTACT US  |  TERMS AND CONDITIONS  |   TESTIMONIALS  |  PRIVACY POLICY  |  QUALITY POLICY  |  COMPLAINTS POLICY  |  SITEMAP
2019 © C&P Medical Trading Ltd

C&P Medical Trading Ltd is an Appointed Representative of Complete Leasing Solutions Ltd, which is authorised and regulated by the Financial Conduct Authority FRN 683991